PP
RCKT icon

PDT Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

PDT Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$668K Sell
186,596
-34,288
-16% -$136K 0.04% 386
2025
Q4 		$775K Sell
220,884
-45,098
-17% -$154K 0.05% 369
2025
Q3 		$867K Hold
265,982
– – 0.05% 376
2025
Q2 		$652K Buy
+265,982
New +$1.35M 0.04% 489
2022
Q4 		– Sell
-90,217
Closed -$1.44M – 845
2022
Q3 		$1.44M Sell
90,217
-22,512
-20% -$351K 0.22% 133
2022
Q2 		$1.55M Buy
112,729
+48,505
+76% +$578K 0.14% 239
2022
Q1 		$1.02M Buy
+64,224
New +$1.11M 0.09% 365

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return